Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

To understand the molecular basis for hemophilia B in patients with little or no circulating Factor IX antigen, a patient who had less than 0.2% circulating Factor IX antigen (Factor IXSeattle 2) was selected for analysis of his Factor IX gene. Genomic DNA fragments from the abnormal gene were clone...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Schach, B G, Yoshitake, S, Davie, E W
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1987
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113155
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!